Literature DB >> 6338184

Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.

C R Hind, G A Tennent, D J Evans, M B Pepys.   

Abstract

The fibril protein in three cases of systemic amyloidosis associated with renal adenocarcinoma was identified as amyloid A protein (AA) using immunohistochemical staining techniques. Amyloid P component was also present in all deposits. In one case unfixed snap frozen tissues were studied directly whilst in the other two, which were investigated retrospectively, fixed paraffin sections were stained by immunofluorescence and immunoperoxidase methods after treatment with trypsin. Enzymatic digestion was necessary to restore reactivity with anti-AP but anti-AA reacted well without any such treatment. These findings establish that renal carcinoma, the carcinoma most frequently associated with systemic amyloidosis, causes the same type of secondary or reactive systemic amyloid as chronic infections and inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338184     DOI: 10.1002/path.1711390207

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

1.  Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins.

Authors:  C A van de Kaa; P R Hol; J Huber; R P Linke; C J Kooiker; E Gruys
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Systemic amyloid associated with carcinoma of the bronchus.

Authors:  I Richmond; P S Hasleton; S Samadian
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

3.  Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?

Authors:  M L Baltz; I F Rowe; D Caspi; W G Turnell; M B Pepys
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

4.  Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.

Authors:  Jung-Mo Ahn; Hye-Jin Sung; Yeon-Hee Yoon; Byung-Gyu Kim; Won Suk Yang; Cheolju Lee; Hae-Min Park; Bum-Jin Kim; Byung-Gee Kim; Soo-Youn Lee; Hyun-Joo An; Je-Yoel Cho
Journal:  Mol Cell Proteomics       Date:  2013-10-01       Impact factor: 5.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.